These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 14669280)

  • 1. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
    Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
    Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
    Yang DH; Smith ER; Cohen C; Wu H; Patriotis C; Godwin AK; Hamilton TC; Xu XX
    Cancer; 2002 May; 94(9):2380-92. PubMed ID: 12015763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
    Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
    Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
    Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
    Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
    He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
    Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
    Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
    Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
    Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
    Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
    Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
    Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
    Wang W; Bergh A; Damber JE
    Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.
    Kohlberger P; Muller-Klingspor V; Heinzl H; Obermair A; Breitenecker G; Leodolter S
    Anticancer Res; 2002; 22(6B):3541-4. PubMed ID: 12552953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
    Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
    Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic precursors of ovarian epithelial tumors.
    Resta L; Russo S; Colucci GA; Prat J
    Obstet Gynecol; 1993 Aug; 82(2):181-6. PubMed ID: 8336861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chronic inflammation-induced basement membrane changes on esophageal carcinogenesis].
    Zhang GH; Su M; Tian DP
    Ai Zheng; 2005 Sep; 24(9):1071-5. PubMed ID: 16159427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
    Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
    Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.